Yep. That’s it, Stubborn. Can’t blame the company for focusing on the human side of things, as that would have/should have been huge, but it’s tough to fight an incestuous relationship between a $1T+/year industry and a federal judge (now on the BOD for a competing bio/stem cell co), an FDA chair (with long-standing previous, and now current ties to big pharm), and a seated Senator (who gets large campaign contributions from big pharm), all of questionable motives, loyalties and integrity.
News 
Market Data 
Discover 
